Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “chimeric”

309 pharma patents match "chimeric" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 309
Index total 30,257
Page 1 / 13

Quick answer

This filtered view shows 309 pharmaceutical patents matching "chimeric" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

309 results for “chimeric” · 30,257 patents in full index Clear search

  1. US 12428463

    Chimeric antigen receptors targeting abnormal glycobiology

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 30, 2025 · Expires Sep 25, 2045

    granted
  2. US 12421292

    Anti-DLL3 chimeric antigen receptors and uses thereof

    Legend Biotech Ireland Limited · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  3. US 12415867

    Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof

    The Board of Regents of the University of Oklahoma · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  4. US 12410232

    Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor

    The Board of Regents of the University of Texas System · Granted Sep 9, 2025 · Expires Sep 4, 2045

    granted
  5. US 12404347

    Glucuronoxylomannan (GXM) receptor chimeric antigen receptors and use thereof

    The Board of Regents of the University of Texas System · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  6. US 12398194

    Cell lexpressing two chimeric antigen receptors (CARs) at the cell surface

    AUTOLUS LIMITED · Granted Aug 26, 2025 · Expires Aug 21, 2045

    granted
  7. US 12371466

    Chimeric antigen receptor and methods of use thereof

    The Regents of the University of California · Granted Jul 29, 2025 · Expires Jul 24, 2045

    granted
  8. US 12370261

    Chimeric peptides for antisense delivery

    Sarepta Therapeutics, Inc. · Granted Jul 29, 2025 · Expires Jul 24, 2045

    granted
  9. US 12365879

    Synthetic chimeric poxviruses

    TONIX PHARMA LIMITED · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  10. US 12358988

    Proteolytically cleavable chimeric polypeptides and methods of use thereof

    The Regents of the University of California · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  11. US 12351638

    Chimeric antigen receptors targeting BCMA and methods of use thereof

    LEGEND BIOTECH USA INC. · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  12. US 12351614

    CLEC9A-based chimeric protein complexes

    Orionis Biosciences, Inc · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  13. US 12338459

    DNA-chimeric antigen receptor T cells for immunotherapy

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jun 24, 2025 · Expires Jun 19, 2045

    granted
  14. US 12311029

    Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of indoleamine 2,3-dioxygenase (IDO) protein

    Northwestern University · Granted May 27, 2025 · Expires May 22, 2045

    granted
  15. US 12310988

    BCMA chimeric antigen receptors and uses thereof

    The Board of Regents of the University of Texas System · Granted May 27, 2025 · Expires May 22, 2045

    granted
  16. US 12304968

    T-cells expressing anti-LIV1 chimeric antigen receptor

    CRISPR THERAPEUTICS AG · Granted May 20, 2025 · Expires May 15, 2045

    granted
  17. US 12304942

    Cell comprising a chimeric antigen receptor or a transgenic T-cell receptor and comprising a chimeric TNF receptor

    AUTOLUS LIMITED · Granted May 20, 2025 · Expires May 15, 2045

    granted
  18. US 12297243

    Methods and compositions for reducing the immunogenicity of chimeric notch receptors

    Cell Design Labs, Inc. · Granted May 13, 2025 · Expires May 8, 2045

    granted
  19. US 12297259

    Aspergillus antigen chimeric receptors and use thereof

    The Board of Regents of the University of Texas System · Granted May 13, 2025 · Expires May 8, 2045

    granted
  20. US 12291557

    Chimeric TIM4 receptors and uses thereof

    Cero Therapeutics Holdings, Inc. · Granted May 6, 2025 · Expires May 1, 2045

    granted
  21. US 12281164

    Genetically engineered dual-targeting chimeric antigen receptor and use thereof

    WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  22. US 12269888

    Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

    Century Therapeutics, Inc. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  23. US 12269860

    Compositions and methods comprising engineered chimeric antigen receptor and modulator of CAR

    AUTOLUS LIMITED · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  24. US 12241068

    CD79-specific chimeric antigen receptor

    AUTOLUS LIMITED · Granted Mar 4, 2025 · Expires Feb 27, 2045

    granted